Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.
Please read the tutorial at this link: https://ebookbell.com/faq
We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.
For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.
EbookBell Team
4.7
86 reviewsSummaryBackground Carotid revascularisation, comprising either carotid endarterectomy or stenting, is offered to patients Lancet Neurol 2025; 24: 389–99with carotid stenosis to prevent stroke based on the results of randomised trials conducted more than 30 years ago. See Comment page 372Since then, medical therapy for stroke prevention has improved. We aimed to assess whether patients with *Contributed equallyasymptomatic and symptomatic carotid stenosis with a low or intermediate predicted risk of stroke, who received †ECST-2 investigators are listed optimised medical therapy (OMT), would benefit from additional revascularisation.in the appendix (pp 2–3)Department of Vascular Methods The Second European Carotid Surgery Trial (ECST-2) is a muloutcome adjudication, which was conducted at 30 centres with stroke anEurope and Canada. Patients aged 18 years or older with asymptomatic or greater, and a 5-year predicted risk of ipsilateral stroke of less than 20% (e[CAR] score), were recruited. Patients were randomly assigned to eithelarisation (1:1) using a web-based system. The primary outcome for this 2-youtcome composite of: (1) periprocedural death, fatal stroke, or fatal myo(3) non-fatal myocardial infarction; or (4) new silent cerebral infarction ontreat using the win ratio—ie, each patient in the OMT alone group was comOMT plus revascularisation group, with a win declared for the patient withwas declared if neither patient in the pair had a better outcome). The win ratin the OMT alone group divided by the number of wins in the OMT pluregistered with the ISRCTN Registry (ISRCTN97744893) and is ongoing.
